Better Survival in Kidney Cancer After Stopping Therapy for Immune-Related AEs

(MedPage Today) — DENVER — Patients who discontinued treatment for advanced kidney cancer because of immune-related adverse events (irAEs) had a trend toward better survival and longer time to treatment failure, according to long-term follow…